Yahoo Web Search

Search results

    • Why Moderna Stock Is a No-Brainer Buy Right Now

      The Motley Fool via AOL· 4 hours ago

      That's changing. On May 31, Moderna won U.S. Food and Drug Administration (FDA) approval for its respiratory syncytial virus (RSV) vaccine mResvia. This approval of a second ...